The findings demonstrated that the high-risk group was enriched for several processes linked to the progression of tumor proliferation, including the cell cycle, the ERBB signaling pathway, mismatch repair, the p53 signaling pathway, ubiquitin-mediated protein hydrolysis, and the WNT signaling pathway (Figure 6A). The gene discussed is EGFR; the disease is neoplasm.